Literature DB >> 573373

Anti-inflammatory effect of warfarin and vitamin K1.

F W Eichbaum, O Slemer, S B Zyngier.   

Abstract

1. Sodium warfarin, given by oral or by parenteral route, displays a pronounced anti-inflammatory effect in the formaldehyde and carrageenan induced rat paw edema. This effect becomes patent not only when the warfarin application precedes the local injection of the irritant substance (prophylactic effect), but also when it is given to animals with already developed inflammatory reactions (therapeutic effect). 2. The active doses of Na warfarin lie between 0.5 and 5.0 mg/kg. Smaller as well as higher doses show a reduced anti-inflammatory effect. 3. A marked anti-inflammatory effect can be noted already 90 min after drug injection at a still normal prothrombin level. 4. Vitamin K1 (phylloquinone), given by oral or parenteral route, in doses from 1.6 mg/kg upwards, shows a marked anti-inflammatory effect both in the prophylactic and the therapeutic rat paw test. Vitamin K3 is devoid of any anti-inflammatory activity. 5. The anti-inflammatory effect of both sodium warfarin and of vitamin K1 in rats, is not interfered with by previous adrenalectomy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573373     DOI: 10.1007/bf00498462

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Role of vitamin K in electron transport.

Authors:  W D WOISLAIT
Journal:  Fed Proc       Date:  1961-12

2.  Vitamin K and other quinones as coenzymes in oxidative phosphorylation in bacterial systems.

Authors:  A F BRODIE
Journal:  Fed Proc       Date:  1961-12

3.  Extra-anticoagulant effects of oral anticoagulants.

Authors:  F W Eichbaum
Journal:  Arq Bras Cardiol       Date:  1975-12       Impact factor: 2.000

4.  The physiological disposition of dicumarol in man.

Authors:  M WEINER; S SHAPIRO; J AXELROD; J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1950-08       Impact factor: 4.030

5.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

Review 6.  [Oral anticoagulants].

Authors:  E Renk; W G Stoll
Journal:  Fortschr Arzneimittelforsch       Date:  1968

Review 7.  Anticoagulants and cancer. A review.

Authors:  F W Eichbaum
Journal:  Rev Bras Pesqui Med Biol       Date:  1975 Sep-Dec

8.  [Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione].

Authors:  L Fontaine; M Grand; Y Quentin; S Merle
Journal:  Med Pharmacol Exp Int J Exp Med       Date:  1965

9.  The resolution of thermal oedema at various temperatures under coumarin treatment.

Authors:  N B Piller
Journal:  Br J Exp Pathol       Date:  1975-02

10.  Tissue levels of (3(-14)C) coumarin in the rat: distribution and excretion.

Authors:  N B Piller
Journal:  Br J Exp Pathol       Date:  1977-02
View more
  7 in total

1.  Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women.

Authors:  Mette Kristensen; Jane Kudsk; Susanne Bügel
Journal:  Eur J Nutr       Date:  2008-09-17       Impact factor: 5.614

2.  Dichotomal effect of the coumadin derivative warfarin on inflammatory signal transduction.

Authors:  Arnon P Kater; Maikel P Peppelenbosch; Dees P M Brandjes; Mika Lumbantobing
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 3.  Clinical Advances in Immunonutrition and Atherosclerosis: A Review.

Authors:  Ana María Ruiz-León; María Lapuente; Ramon Estruch; Rosa Casas
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

4.  Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement.

Authors:  Huma Shafique; Naeem Mahmood Ashraf; Amir Rashid; Asifa Majeed; Tayyaba Afsar; Ann K Daly; Ali Almajwal; Nawaf W Alruwaili; Azmat Ullah Khan; Suhail Razak
Journal:  Front Cardiovasc Med       Date:  2022-06-10

5.  Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms.

Authors:  Anil Can; Victor M Castro; Dmitriy Dligach; Sean Finan; Sheng Yu; Vivian Gainer; Nancy A Shadick; Guergana Savova; Shawn Murphy; Tianxi Cai; Scott T Weiss; Rose Du
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

6.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

7.  Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.

Authors:  Songnan Wen; Cristina Pislaru; Kristi H Monahan; Stephanie M Barnes; David O Hodge; Douglas L Packer; Sorin V Pislaru; Samuel J Asirvatham
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-18       Impact factor: 3.947

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.